Elimination of Ascorbic Acid After High‐Dose Infusion in Prostate Cancer Patients: A Pharmacokinetic Evaluation

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Basic & Clinical Pharmacology & Toxicology

• Publication date

  2015-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/bcpt.12323PMID 25220574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer

  2013cited by this paper
• Influence of tumour micro-environment heterogeneity on therapeutic response

  2013cited by this paper
• Principles of anticancer drug development

  2013cited by this paper
• Pharmacological ascorbate induces cytotoxicity in prostate cancer cells through ATP depletion and induction of autophagy

  2012cited by this paper
• Ascorbate and dehydroascorbic acid as biomarkers of oxidative stress: validity of clinical data depends on vacutainer system used.

  2012cited by this paper
• Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer

  2012cited by this paper
• Enhanced antitumor activity of vitamin C via p53 in cancer cells.

  2012cited by this paper
• Principles of Anticancer Drug Development

  2011cited by this paper
• Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer.

  2010cited by this paper
• Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects

  2010cited by this paper
• Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs

  2010cited by this paper
• Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects.

  2009cited by this paper
• Phase I clinical trial of i.v. ascorbic acid in advanced malignancy.

  2008cited by this paper
• Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.

  2008cited by this paper
• Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice

  2008cited by this paper
• Specific Aquaporins Facilitate the Diffusion of Hydrogen Peroxide across Membranes*

  2007cited by this paper
• Ascorbate and Dehydroascorbic Acid as Reliable Biomarkers of Oxidative Stress: Analytical Reproducibility and Long-term Stability of Plasma Samples Subjected to Acidic Deproteinization

  2007cited by this paper
• Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo

  2007cited by this paper
• H2O2-mediated Cytotoxicity of Pharmacologic Ascorbate Concentrations to Neuroblastoma Cells: Potential Role of Lactate and Ferritin

  2006cited by this paper
• Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate

  2006cited by this paper
• Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

  2005cited by this paper
• Transport and intracellular accumulation of vitamin C in endothelial cells: relevance to collagen synthesis.

  2005cited by this paper
• Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use

  2004cited by this paper
• Indexing glomerular filtration rate to suit children.

  2003cited by this paper
• Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

  2001cited by this paper
• Determination of ascorbic acid and dehydroascorbic acid in biological samples by high-performance liquid chromatography using subtraction methods: reliable reduction with tris[2-carboxyethyl]phosphine hydrochloride.

  2000cited by this paper
• Pharmacokinetic perspectives on megadoses of ascorbic acid.

  1997cited by this paper
• Pharmacokinetic Model of Ascorbic Acid in Healthy Male Volunteers During Depletion and Repletion

  1997cited by this paper
• Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.

  1996cited by this paper
• Synergistic antitumor activity of vitamins C and K3 on human urologic tumor cell lines.

  1996cited by this paper
• Predictors of body surface area.

  1992cited by this paper
• Measurement of Vitamin C in Blood Components by High‐Performance Liquid Chromatography

  1987cited by this paper
• High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.

  1985cited by this paper
• Evidence of rebound effect with ascorbic acid.

  1984cited by this paper
• Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

  1979cited by this paper
• Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer.

  1978cited by this paper
• The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer.

  1974cited by this paper

• Therapeutic Potential of High Dose Vitamin C in Cancer: Mechanisms, Clinical Evidence and Future Directions

  2025cites this paper
• The pharmacology of vitamin C.

  2025cites this paper
• High-dose Vitamin C Blocks HOCl Production by Myeloperoxidase: A Potential Therapeutic Strategy

  2025influential citation
• Postoperative Delirium and Vitamin C: Rethinking Unfavorable Outcomes Through the Lens of Underdosing

  2025cites this paper
• Development of Iron-Chelating/Antioxidant Nutraceuticals and Natural Products as Pharmaceuticals for Clinical Use in Diseases with Free Radical Pathologies

  2025influential citation
• The impact of vitamin C supplementation on the perioperative outcomes after total hip and knee arthroplasty: a systematic review and meta-analysis

  2025cites this paper
• Ascorbic acid prevents stress-induced hypercoagulability in overweight and obese individuals

  2024cites this paper
• Combination of High-Dose Parenteral Ascorbate (Vitamin C) and Alpha-Lipoic Acid Failed to Enhance Tumor-Inhibitory Effect But Increased Toxicity in Preclinical Cancer Models

  2024cites this paper
• Vulnerability of Antioxidant Drug Therapies on Targeting the Nrf2-Trp53-Jdp2 Axis in Controlling Tumorigenesis

  2024cites this paper
• Anti-tumor mechanism and influencing factors of clinical efficacy of high-dose vitamin C treatment

  2024influential citation
• High-dose vitamin C as a metabolic treatment of cancer: a new dimension in the era of adjuvant and intensive therapy

  2024cites this paper
• Safety and Pharmacokinetics of a Combined Antioxidant Therapy against Myocardial Reperfusion Injury: A Phase 1 Randomized Clinical Trial in Healthy Humans

  2024cites this paper
• Critical evaluation of intravenous vitamin C in practice

  2024cites this paper
• The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency

  2024cites this paper
• Vitamin C promotes ACE2 degradation and protects against SARS‐CoV‐2 infection

  2023cites this paper
• Vitamin C – a scoping review for Nordic Nutrition Recommendations 2023

  2023cites this paper
• Role of ascorbic acid in cardiac allograft vasculopathy

  2023cites this paper
• Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications

  2023cites this paper
• Therapeutic Potential of Ascorbic Acid in the Management of Alzheimer's Disease: An Update.

  2023cites this paper
• Hmong microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C): A phase II clinical study protocol

  2023cites this paper
• Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study

  2022cites this paper
• Role of Vitamin C in Selected Malignant Neoplasms in Women

  2022cites this paper
• STUDY REGARDING A NEW EXTENDED-RELEASE CALCIUM ASCORBATE AND HESPERIDIN SOLID ORAL FORMULATION

  2022cites this paper
• Perspectives of vitamin C upregulating regulatory T cells in the era of thrombopoietin receptor agonists for immune thrombocytopenia

  2022cites this paper
• Diverse antitumor effects of ascorbic acid on cancer cells and the tumor microenvironment

  2022cites this paper
• Pharmacological Basis for Abrogating Myocardial Reperfusion Injury Through a Multi-Target Combined Antioxidant Therapy

  2022influential citation
• Vitamin C is an efficient natural product for prevention of SARS-CoV-2 infection by targeting ACE2 in both cell and in vivo mouse models

  2022cites this paper
• Ergothioneine as a Natural Antioxidant Against Oxidative Stress-Related Diseases

  2022cites this paper
• High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer

  2021cites this paper
• The Role of 2-Oxoglutarate Dependent Dioxygenases in Gliomas and Glioblastomas: A Review of Epigenetic Reprogramming and Hypoxic Response

  2021cites this paper
• High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients

  2021cites this paper
• The role of vitamin C in epigenetic cancer therapy.

  2021cites this paper
• Peroxiredoxin 2 oxidation reveals hydrogen peroxide generation within erythrocytes during high-dose vitamin C administration

  2021cites this paper
• Parenteral high-dose ascorbate - A possible approach for the treatment of glioblastoma (Review)

  2021cites this paper
• Vitamin C and Sepsis

  2021cites this paper
• Any Role of High-Dose Vitamin C for Septic Shock in 2021?

  2021cites this paper
• The Challenges and Effects of Ascorbic Acid Treatment of Acute Pancreatitis: A Systematic Review and Meta-Analysis of Preclinical and Clinical Studies

  2021cites this paper
• Surface-engineered liposomal particles of calcium ascorbate with fenugreek galactomannan enhanced the oral bioavailability of ascorbic acid: a randomized, double-blinded, 3-sequence, crossover study

  2021cites this paper
• The Role of Vitamin C in Cancer Prevention and Therapy: A Literature Review

  2021cites this paper
• Effect of high-dose intravenous vitamin C on point-of-care blood glucose level in septic patients: a retrospective, single-center, observational case series

  2021cites this paper
• Effects of High-dose Intravenous Vitamin C on Point-of-Care Blood Glucose Level in Septic Patients: A Retrospective, Single-Center, Observational Case Series

  2020cites this paper
• Vitamin C Administration by Intravenous Infusion Increases Tumor Ascorbate Content in Patients With Colon Cancer: A Clinical Intervention Study

  2020cites this paper
• Vitamin C

  2020cites this paper
• Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications

  2020cites this paper
• Could Ergothioneine Aid in the Treatment of Coronavirus Patients?

  2020cites this paper
• Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases

  2020cites this paper
• On the effect of vitamin C intake on human health: How to (mis)interprete the clinical evidence

  2020cites this paper
• Harm of IV High-Dose Vitamin C Therapy in Adult Patients: A Scoping Review

  2020cites this paper
• The in vitro Analysis of Quality of Ovarian Follicle Culture Systems Using Time-Lapse Microscopy and Quantitative Real-Time PCR

  2020cites this paper
• Pharmacokinetics of intravenous administered two different high doses of ascorbic acid in healthy beagle dogs

  2019cites this paper
• Pro- and Antioxidant Effects of Vitamin C in Cancer in correspondence to Its Dietary and Pharmacological Concentrations

  2019cites this paper
• In vitro Cytotoxicity and Pharmacokinetic Evaluation of Pharmacological Ascorbate in Dogs

  2019cites this paper
• The Pharmacokinetics of Vitamin C

  2019cites this paper
• Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology

  2019cites this paper
• Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge

  2018cites this paper
• Intravenous vitamin C in the treatment of allergies: an interim subgroup analysis of a long-term observational study

  2018cites this paper
• Vitamin C and Helicobacter pylori Infection: Current Knowledge and Future Prospects

  2018cites this paper
• Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer

  2018cites this paper
• Weekly ascorbic acid infusion in castration-resistant prostate cancer patients: a single-arm phase II trial

  2017cites this paper
• Parkinsonism and Vitamin C Deficiency.

  2017cites this paper
• Total lymphocyte count in cancer patients with lymphopenia treated with intravenous vitamin C: Results of an observational study

  2017cites this paper
• Ascorbic acid: still controversial when used against cancer resistance?

  2017cites this paper
• University of Southern Denmark Weekly ascorbic acid infusion in castration-resistant prostate cancer patients A single-arm phase II trial

  2017cites this paper
• Effect of Intravenous High Dose Vitamin C on Postoperative Pain and Morphine Use after Laparoscopic Colectomy: A Randomized Controlled Trial

  2016cites this paper
• Vitamin C, a Multi-Tasking Molecule, Finds a Molecular Target in Killing Cancer Cells.

  2016cites this paper
• Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice.

  2016cites this paper
• Intravenous Vitamin C in Intravenous Vitamin C in Cancer Care: Evidence Review and Cancer Care: Evidence Review and Practical Guidance for Integrative Practical Guidance for Integrative Oncology Practitioners Oncology Practitioners

  year unknowncites this paper